FOX News
A man who ran three pet shops in the Hudson Valley has been permanently barred from selling animals in New York and must pay $15,000 in restitution to people who bought sickly puppies.
Jerri Kurdila and Eric Amshoff had both worked at Duke Energy in Monroe, Ohio, for years.
Health News Headlines - Yahoo News
By Lawrence Hurley WASHINGTON (Reuters) - President Donald Trump was set to unveil his pick for a lifetime job on the U.S. Supreme Court on Tuesday as Democrats, still fuming over the Republican-led Senate's refusal to act on former President Barack Obama's nominee last year, girded for a fight. Trump said on Monday he would reveal his choice to replace conservative Justice Antonin Scalia, who died in February 2016, at the White House at 8 p.m. on Tuesday (0100 GMT on Wednesday). The court is ideologically split with four conservative justices and four liberals, and Trump's pick is expected to restore its conservative majority.
Aetna, along with UnitedHealth Group Inc. , has largely exited that individual business for 2017. The individual market and other aspects of insurance are likely to change over the next few years as U.S. President Donald Trump and the Republican-led Congress move to repeal and replace former President Barack Obama's health reform law, often called Obamacare. Aetna, the No. 3 U.S. health insurer, said it was still deciding how to proceed on Humana, but analysts said they thought it was unlikely a deal would go forward.
A bitter defeat in a U.S. patents case sent shares in Teva Pharmaceutical Industries plummeting on Tuesday, the latest in a series of setbacks that has investors calling for major changes at the world's largest generic drugmaker. A U.S. District Court on Monday rejected four out of five of Israel-based Teva's claims of patent infringement on its top-selling multiple sclerosis treatment Copaxone, potentially opening the door for generic competition. The patents cover a 40-mg injection of Copaxone that patients administer three times a week.
The looming foreign takeovers of biotech group Actelion and agrichemicals firm Syngenta look set to trigger the biggest shake-up in the Swiss blue-chip SMI index in years just as passive investing makes membership increasingly important. Analysts say specialty chemicals group Lonza may be set to join the Swiss club of the 20 best capitalized and most liquid shares, whose ranks could be thinned even further by the time that the next review takes place in June, analysts say. "It is pretty clear that under the current selection list by the Swiss exchange, Lonza could be taken into the SMI," said Thomas Kuehne, fund manager at Liechtensteinische Landesbank.
Switzerland on Tuesday said it would lift its 40-year ban on gay and bisexual men giving blood but will still prohibit donations from those who have had sex in the last year. The policy change was approved by the Swiss Agency for Therapeutic Products (Swissmedic), a federal regulator, following an appeal from Swiss Transfusion SRC, a division of the Red Cross responsible for blood products. Switzerland's 1977 ban on blood donations from men who have sex with men (MSM) preceded the discovery of HIV.
U.S. President Donald Trump, who has accused drugmakers of "getting away with murder" on prices, will meet executives from the pharmaceutical industry at the White House on Tuesday. Switzerland's Novartis said its chief executive Joe Jimenez, chairman-elect of the Pharmaceutical Research and Manufacturers of America (PhRMA), would be among those attending, after the White House announced the meeting on Monday. Trump and the Republican-majority Congress, as well as raising concerns over medicine prices, have also begun rolling back former President Barack Obama's signature healthcare legislation.
Excluding genetic and behavioral factors, such as smoking and alcohol consumption, what can be done to help prevent cancer? What links can currently be established between cancer and diet? When Japanese people emigrate to Hawaii and start eating processed products, their cancer risk increases by a third.
Reuters: Health News
(Reuters) - A bitter defeat in a U.S. patents case sent shares in Teva Pharmaceutical Industries plummeting on Tuesday, the latest in a series of setbacks that has investors calling for major changes at the world's largest generic drugmaker.
NYT > Health
Researchers had suspected that heat stroke, infections or pesticides were behind a disease that killed about 40 percent of children affected, but it seems lychees were to blame.
No comments:
Post a Comment